Given the growing role of biobanks within the life science industry, ISO has released a standard, ISO 20387:2018, designed specifically for biobanks. ISO 20387:2018 covers requirements for all aspects of managing biobanks, including structural, personnel, facilities, processes, and equipment. This standard also covers quality management systems requirements and best practices for sample handling, including collection, preservation, transport, distribution, and traceability of biological materials.
Biobanks are expected to maintain high standards of sample collection, preservation, quality assurance, traceability, and distribution. ISO 20387 accreditation serves as a clear indicator to stakeholders, such as donors, users, and investors, regarding the biobank’s reliability and competencies. Consequently, stakeholders have more trust in the biobank’s capacity to deliver consistent results and meet critical requirements. However, complying with the requirements of the standard could be challenging for biobanks. An informatics tool, such as a Biospecimen Management Software, can help biobanks meet the various requirements of ISO 20387 seamlessly and breeze through regulatory audits.
- The significance of obtaining ISO 20387:2018 accreditation for biobanks
- The general, structural, resource, process, and quality management system requisites necessary for achieving ISO 20387 compliance
- How a biospecimen management software can help you comply with ISO 20387 and maintain high-quality, well-documented samples that are fit for use in research
When: 9 AM PDT/5 PM BST, 28 March 2023 (Tue)
Webinar Duration: 40 minutes
The webinar includes 30 minutes of presentation and 10 minutes of the Q&A session.
Who Should Attend?
Recommended attendees include biobank managers, quality managers, and technicians.
Please fill the form to receive the webinar invite!
Martha is a chemist with expertise in diverse areas of analytical chemistry. She had worked as an analyst at a licensed 3rd party analytical laboratory where she focused on developing and validating analytical methods for bioequivalence studies. Later, she served as a quality control expert in the analytical domain and as a monitor in clinical trials. Her interest in the clinical industry led her to be a part of two of the biggest hospitals in Mexico where she gained expertise in hematology, microbiology, and blood banking. Later, she became a member of the team of forensic chemical experts and started working from day one as a specialist in narcotics and drugs. This enabled her to gain rich experience in GC-MS, FTIR, HPLC-MS/MS, ICP-MS, and other analytical techniques for the separation, detection, and quantification of different molecules such as cannabinoids. She had participated in multiple oral trials defending her legal opinions and worked as an expert consultant. She had worked on the synthesis of small molecules for testing them on multi-drug resistant bacteria and mycobacteria, further developing her analytical skills in column chromatography, thin-layer chromatography, microbiology, and compound elucidation by NMR and HRMS. She carried out a research stay at the University of Barcelona with the organic synthesis team. She had also worked on natural products in France and presented her work at conferences in the USA and France. She received awards and accolades for her exceptional work. She has participated in several conferences as a moderator as well.
Martha holds a bachelor’s degree in Clinical Chemistry from the Faculty of Medicine UANL and a master’s degree in Pharmacy from the Faculty of Chemical Sciences UANL, Mexico.